The E2F1 promoter region between −168 and +31 was pulled down by an anti-ISX antibody and was shown to correlate with the expression level of E2F1 in hepatoma cells, particularly in Hep3B and SK-Hep1 cells (Figure 2E). This evidence concerns the gene ISX and hepatocellular carcinoma.